Advanced search
Publication Cover
Expert Review of Obstetrics & Gynecology Volume 8, 2013 - Issue 4
Journal homepage
25
Views
6
CrossRef citations to date
0
Altmetric
Review

Use of the etonogestrel-releasing contraceptive implant

Jaclyn Grentzer Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, 4533 Clayton Avenue, St. Louis, MO 63110, USA
,
Colleen McNicholas Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, 4533 Clayton Avenue, St. Louis, MO 63110, USA
&
Jeffrey F Peipert Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, 4533 Clayton Avenue, St. Louis, MO 63110, USA. [email protected]
Pages 337-344 | Published online: 10 Jan 2014

References

  • Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 84(5), 478–485 (2011).
  • Hatcher RA, Trussell J, Nelson A, Cates W, Stewart F, Kowal D. Contraceptive Technology. Ardent Media, NY, USA (2007).
  • Winner B, Peipert JF, Zhao Q et al. Effectiveness of long-acting reversible contraception. N. Engl. J. Med. 366(21), 1998–2007 (2012).
  • Peipert JF, Zhao Q, Allsworth JE et al. Continuation and satisfaction of reversible contraception. Obstet. Gynecol. 117(5), 1105–1113 (2011).
  • Croxatto H, Díaz S, Vera R, Etchart M, Atria P. Fertility control in women with a progestogen released in microquantities from subcutaneous capsules. Am. J. Obstet. Gynecol. 105(7), 1135–1138 (1969).
  • Hatasaka H. Implantable levonorgestrel contraception: 4 years of experience with Norplant. Clin. Obstet. Gynecol. 38(4), 859–871 (1995).
  • Trussell J. Contraceptive failure in the United States. Contraception 83(5), 397–404 (2011).
  • Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur. J. Contracept. Reprod. Health Care 13(Suppl. 1), 4–12 (2008).
  • Finer LB, Jerman J, Kavanaugh ML. Changes in use of long-acting contraceptive methods in the United States, 2007–2009. Fertil. Steril. 98(4), 893–897 (2012).
  • Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil. Steril. 91(5), 1646–1653 (2009).
  • Wenzl R, van Beek A, Schnabel P, Huber J. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. Contraception 58(5), 283–288 (1998).
  • Díaz J, Faúndes A, Díaz M, Marchi N. Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil. Contraception 47(2), 169–175 (1993).
  • Huber J, Wenzl R. Pharmacokinetics of Implanon. An integrated analysis. Contraception 58(Suppl. 6), S85–S90 (1998).
  • Mornar S, Chan LN, Mistretta S, Neustadt A, Martins S, Gilliam M. Pharmacokinetics of the etonogestrel contraceptive implant in obese women. Am. J. Obstet. Gynecol. 207(2), 110.e1–110.e6 (2012).
  • Xu H, Wade JA, Peipert JF, Zhao Q, Madden T, Secura GM. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet. Gynecol. 120(1), 21–26 (2012).
  • Van den Bosch T, Donders GG, Riphagen I et al. Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant. Ultrasound Obstet. Gynecol. 20(4), 377–380 (2002).
  • Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H. Ovarian function during the use of a single contraceptive implant: implanon compared with Norplant. Fertil. Steril. 69(4), 714–721 (1998).
  • Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst. Rev. 3, CD001326 (2007).
  • Steiner MJ. Contraceptive effectiveness: what should the counseling message be? JAMA 282(15), 1405–1407 (1999).
  • Benfield N. Contraceptive implants. In: Contraception. Shoupe D (Ed.). Wiley-Blackwell, UK, 59 (2011).
  • Levine JP, Sinofsky FE, Christ MF; Implanon US Study Group. Assessment of Implanon insertion and removal. Contraception 78(5), 409–417 (2008).
  • Funk S, Miller MM, Mishell DR Jr et al.; Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 71(5), 319–326 (2005).
  • Ponpuckdee J, Taneepanichskul S. The effects of implanon in the symptomatic treatment of endometriosis. J. Med. Assoc. Thai. 88(Suppl. 2), S7–S10 (2005).
  • Paltieli Y, Eibschitz I, Ziskind G, Ohel G, Silbermann M, Weichselbaum A. High progesterone levels and ciliary dysfunction–a possible cause of ectopic pregnancy. J. Assist. Reprod. Genet. 17(2), 103–106 (2000).
  • Croxatto HB, Mäkäräinen L. The pharmacodynamics and efficacy of Implanon. An overview of the data. Contraception 58(Suppl. 6), S91–S97 (1998).
  • Glasier A. Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception 65(1), 29–37 (2002).
  • Davies GC, Feng LX, Newton JR, Van Beek A, Coelingh-Bennink HJ. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel. Contraception 47(3), 251–261 (1993).
  • Kiriwat O, Patanayindee A, Koetsawang S, Korver T, Bennink HJ. A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand. Eur. J. Contracept. Reprod. Health Care 3(2), 85–91 (1998).
  • Bhatia P, Nangia S, Aggarwal S, Tewari C. Implanon: subdermal single rod contraceptive implant. J. Obstet. Gynaecol. India 61(4), 422–425 (2011).
  • Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception 58(Suppl. 6), S99–S107 (1998).
  • Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. The effects of Implanon on menstrual bleeding patterns. Eur. J. Contracept. Reprod. Health Care 13(Suppl. 1), 13–28 (2008).
  • Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF. A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China. Eur. J. Contracept. Reprod. Health Care 4(2), 85–93 (1999).
  • Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant. Contraception 60(1), 1–8 (1999).
  • Blumenthal PD, Gemzell-Danielsson K, Marintcheva-Petrova M. Tolerability and clinical safety of Implanon. Eur. J. Contracept. Reprod. Health Care 13(Suppl. 1), 29–36 (2008).
  • Nault AM, Peipert JF, Zhao Q, Madden T, Secura GM. Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate. Am. J. Obstet. Gynecol. 208(1), 48.e1–48.e8 (2013).
  • Beerthuizen R, van Beek A, Massai R, Mäkäräinen L, Hout J, Bennink HC. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum. Reprod. 15(1), 118–122 (2000).
  • Pongsatha S, Ekmahachai M, Suntornlimsiri N, Morakote N, Chaovisitsaree S. Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 years. Int. J. Gynaecol. Obstet. 109(3), 223–225 (2010).
  • Canto De Cetina TE, Canto P, Ordonez Luna M. Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception 63(3), 143–146 (2001).
  • Brache V, Faundes A, Alvarez F, Cochon L. Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials. Contraception 65(1), 63–74 (2002).
  • Madden T, Eisenberg DL, Zhao Q, Buckel C, Secura GM, Peipert JF. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement. Obstet. Gynecol. 120(5), 1053–1059 (2012).
  • Guazzelli CA, de Queiroz FT, Barbieri M, Torloni MR, de Araujo FF. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate. Contraception 82(3), 256–259 (2010).
  • Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sá MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception 80(6), 519–526 (2009).
  • Brito MB, Ferriani RA, Meijers JC et al. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial. Thromb. Res. 130(3), 355–360 (2012).
  • Gurtcheff SE, Turok DK, Stoddard G, Murphy PA, Gibson M, Jones KP. Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial. Obstet. Gynecol. 117(5), 1114–1121 (2011).
  • Meade CS, Ickovics JR. Systematic review of sexual risk among pregnant and mothering teens in the USA: pregnancy as an opportunity for integrated prevention of STD and repeat pregnancy. Soc. Sci. Med. 60(4), 661–678 (2005).
  • Harper CC, Blum M, de Bocanegra HT et al. Challenges in translating evidence to practice: the provision of intrauterine contraception. Obstet. Gynecol. 111(6), 1359–1369 (2008).
  • Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception 84(5), 493–498 (2011).
  • Levine AS, Holmes MM, Haseldon C, Butler W, Tsai C. Subdermal contraceptive implant (Norplant) continuation rates among adolescents and adults in a family planning clinic. J. Pediatr. Adolesc. Gynecol. 9(2), 67–70 (1996).
  • Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstet. Gynecol. 120(6), 1298–1305 (2012).
  • Lewis LN, Doherty DA, Hickey M, Skinner SR. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy. Contraception 81(5), 421–426 (2010).
  • Tocce KM, Sheeder JL, Teal SB. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference? Am. J. Obstet. Gynecol. 206(6), 481.e1–481.e7 (2012).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.